New Drugs Development Application Plan

A new immunological preparation for children - Edyltron (Pinotimod) dispersible tablets

Product design and research

  1. The design idea of Ed Er Qiang

    1. Customer - 0- 12 years old children

There are more than 300 million children aged 0-12 in China, and about 100 million urban children

    1. Customer needs

-- Children aged 0-12 are vulnerable to colds and other bacterial infections.

          -- Easy to take

          -- Good taste and good color (because children have a bitter feeling for white, bright colors can distract children's attention and bring beautiful associations)

    1. The product forms a complementary relationship with the newly listed Aderkang, as an adjuvant therapy for children, the four major diseases of children can be taken, but also for the next development of cough, diarrhea and other new drugs pave the way.Strategically speaking, this new product development is an old market, and there is little risk of market development by increasing the usage.

    2. Design ideas for new products

      1. The general name of the product - Pinomod

      2. Easy to take design - dosage form: dispersive tablet, oral liquid, dry suspended syrup

      3. Product specification??Mm mg (approved for children)

      4. Product channels -- hospitals, clinics (through RX sales)

    3. New product design considerations:

      1. Has Pinomod been approved for?This is the basis on which the product is decided, and of course it can be designed according to other prescriptions.


Original Files Download:

LSC0010CN_New Drugs Development Application Plan

LSC0010EN_New Drugs Development Application Plan

Previous
Previous

Work Procedures of New Drugs Development Department

Next
Next

More work on the R&D of Dispersible Pseudoephedrine Hydrochloride Compound Tablets